Compassionate Allowance
Summary: The Compassionate Allowance initiative quickly identifies individuals who undeniably qualify for Social Security Disability Insurance or Supplemental Security Income. Disability benefits for these cases are received within days of filing applications for benefits.
The Social Security Administration’s (SSA) Compassionate Allowance initiative effectively identifies applicants who clearly meet SSA’s criteria of disabling conditions. Claims are processed within days instead of months, so that disability benefits can be expedited quickly.
SSA continues to expand its list of qualifying medical conditions. Currently there are 88 conditions that meet SSA’s definition of disability, which is a condition that renders someone totally unable to work for a year or longer, and could result in death.
Confirmation of the medical diagnosis of the condition is often all that is needed to get approved for benefits under the Compassionate Allowance process. However, the application must be as complete as possible, with supporting medical information easily obtainable.
If you think your condition qualifies under the Compassionate Allowance initiative, Freedom Disability can help prepare a complete application package for you so that you can receive disability benefits as soon as possible. Contact us so that we can help you.
There are currently 88 medical conditions that qualify for Compassionate Allowance consideration. SSA expects to expand this list over time.
Current Compassionate Allowance Conditions
- Acute Leukemia
- Adrenal Cancer - with distant metastases or inoperable, unresectable or recurrent
- Alexander Disease (ALX) - Neonatal and Infantile
- Amyotrophic Lateral Sclerosis (ALS)
- Anaplastic Adrenal Cancer - with distant metastases or inoperable, unresectable or recurrent
- Astrocytoma - Grade III and IV
- Bladder Cancer - with distant metastases or inoperable or unresectable
- Bone Cancer - with distant metastases or inoperable or unresectable
- Breast Cancer - with distant metastases or inoperable or unresectable
- Canavan Disease (CD)
- Cerebro Oculo Facio Skeletal (COFS) Syndrome
- Chronic Myelogenous Leukemia (CML) - Blast Phase
- Creutzfeldt-Jakob Disease (CJD) - Adult
- Ependymoblastoma (Child Brain Tumor)
- Esophageal Cancer
- Farber's Disease (FD) - Infantile
- Friedreichs Ataxia (FRDA)
- Frontotemporal Dementia (FTD), Picks Disease -Type A - Adult
- Gallbladder Cancer
- Gaucher Disease (GD) - Type 2
- Glioblastoma Multiforme (Brain Tumor)
- Head and Neck Cancers - with distant metastasis or inoperable or unresectable
- Infantile Neuroaxonal Dystrophy (INAD)
- Inflammatory Breast Cancer (IBC)
- Kidney Cancer - inoperable or unresectable
- Krabbe Disease (KD) - Infantile
- Large Intestine Cancer - with distant metastasis or inoperable, unresectable or recurrent
- Lesch-Nyhan Syndrome (LNS)
- Liver Cancer
- Mantle Cell Lymphoma (MCL)
- Metachromatic Leukodystrophy (MLD) - Late Infantile
- Niemann-Pick Disease (NPD) - Type A
- Non-Small Cell Lung Cancer - with metastases to or beyond the hilar nodes or inoperable, unresectable or recurrent
- Ornithine Transcarbamylase (OTC) Deficiency
- Osteogenesis Imperfecta (OI) - Type II
- Ovarian Cancer - with distant metastases or inoperable or unresectable
- Pancreatic Cancer
- Peritoneal Mesothelioma
- Pleural Mesothelioma
- Pompe Disease - Infantile
- Rett (RTT) Syndrome
- Salivary Tumors
- Sandhoff Disease
- Small Cell Cancer (of the Large Intestine, Ovary, Prostate, or Uterus)
- Small Cell Lung Cancer
- Small Intestine Cancer - with distant metastases or inoperable, unresectable or recurrent
- Spinal Muscular Atrophy (SMA) - Types 0 And 1
- Stomach Cancer - with distant metastases or inoperable, unresectable or recurrent
- Thyroid Cancer
- Ureter Cancer - with distant metastases or inoperable, unresectable or recurrent
- Alstrom Syndrome
- Amegakaryocytic Thrombocytopenia
- Ataxia Spinocerebellar
- Ataxia Telangiectasia
- Batten Disease
- Bilateral Retinoblastoma
- Cri du Chat Syndrome
- Degos Disease
- Early-Onset Alzheimer’s Disease
- Edwards Syndrome
- Fibrodysplasia Ossificans Progressiva
- Fukuyama Congenital Muscular Dystrophy
- Glutaric Acidemia Type II
- Hemophagocytic Lymphohistiocytosis (HLH), Familial Type
- Hurler Syndrome, Type IH
- Hunter Syndrome, Type II
- Idiopathic Pulmonary Fibrosis
- Junctional Epidermolysis Bullosa, Lethal Type
- Late Infantile Neuronal Ceroid Lipofuscinoses
- Leigh’s Disease
- Maple Syrup Urine Disease
- Merosin Deficient Congenital Muscular Dystrophy
- Mixed Dementia
- Mucosal Malignant Melanoma
- Neonatal Adrenoleukodystrophy
- Neuronal Ceroid Lipofuscinoses, Infantile Type
- Niemann-Pick Type C
- Patau Syndrome
- Primary Progressive Aphasia
- Progressive Multifocal Leukoencephalopathy
- Sanfilippo Syndrome
- Subacute Sclerosis Panencephalitis
- Tay Sachs Disease
- Thanatophoric Dysplasia, Type 1
- Ullrich Congenital Muscular Dystrophy
- Walker Warburg Syndrome
- Wolman Disease
- Zellweger Syndrome
Back to the top
The foregoing information is based on published materials from the Social Security Administration including “Disability Evaluation Under Social Security”. It is meant to serve as an introduction to some of the factors used by the SSA in evaluating cases. It is no way comprehensive. While Freedom Disability Services can help you prepare an effective application for benefits, only the SSA can determine whether or not you qualify. For more information call Freedom today at (866) 761-5942.